Mortality Studies in Dialysis Hemodialysis and Peritoneal Dialysis Patients
Vince Faridani, Jun L Lu, Kamyar Kalantar-Zadeh, Csaba P Kovesdy, Virginia Tech
Carilion School of Medicine, Roanoke, VA; Salem Research |
Jason Jones, John Holmen, Jennifer De Graauw, Anna Jovanovich, Sid Thornton, Michel Chonchol
American Journal of Kidney Diseases - 30 April 2012 (10.1053/j.ajkd.2012.03.014 |
-
Saugar Maripuri, Patrick Arbogast, T. Alp Ikizler, and Kerri L. Cavanaugh
CJASN CJN.10831011; published ahead of print April 19, 2012,doi:10.2215/CJN.10831011
|
|
Ekart R, Kani? V, Pe?ovnik Balon B, Bevc S, Hojs R.
Department of Dialysis, Clinic for Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia.
Kidney Blood Press Res. 2012 Mar 7;35(5):326-331. [Epub ahead of print]
|
Kamyar Kalantar-Zadeh, Elani Streja, Miklos Z. Molnar, Lilia R. Lukowsky,Mahesh Krishnan, Csaba P. Kovesdy, and Sander Greenland
Am. J. Epidemiol. first published online March 16, 2012 doi:10.1093/aje/kwr384 |
Finnian R. Mc Causland, Sushrut S. Waikar, Steven M., Brunelli
Kidney International , (14 March 2012) | doi:10.1038/ki.2012.4
|
Alberto Pilotto, Daniele Sancarlo, Filippo Aucella, Andrea Fontana, Filomena Addante, Massimiliano Copetti, Francesco Panza, Giovanni F.M. Strippoli, and Luigi Ferrucci. Rejuvenation Research.
February 2012, 15(1): 82-88. doi:10.1089/rej.2011.1210. |
Gregory C. Shearer, Juan J. Carrero, Olof Heimbürger, Peter Barany, Peter Stenvinkel
Journal of Renal Nutrition - March 2012 (Vol. 22, Issue 2, Pages 277-283,
DOI: 10.1053/j.jrn.2011.05.005) |
Duong U, Kalantar-Zadeh K, Molnar MZ, Zaritsky JJ,
Teitelbaum I, Kovesdy CP, Mehrotra R:
Am J Nephrol 2012;35:198-208 (DOI: 10.1159/000335685) |
Park, J. H., Kim, S. B., Shin, H. S., Jung, Y. S. and Rim, H. (2012), Geriatric Nutritional Risk Index May Be a Significant Predictor of Mortality in Korean Hemodialysis Patients: A Single Center Study. Therapeutic Apheresis and Dialysis. doi: 10.1111/j.1744-9987.2011.01046.x |
Chia-Jui Tsai, El-Wui Loh, Ching-Heng Lin, Tung-Min Yu, Chin-Hong Chan and Tsuo-Hung Lan
Accepted manuscript online: 19 JAN 2012 09:45PM EST |
DOI: 10.1111/j.1440-1797.2012.01571.x |
Eduardo Lacson, Jr, Nien-Chen Li, Sandie Guerra-Dean, Michael Lazarus,
Raymond Hakim, and Fredric O. Finkelstein
Nephrol. Dial. Transplant. first published online January 23, 2012 doi:10.1093/ndt/gfr778 |
Author Interview: Drs. Ting-Ting Chao and Wen-Je Ko
Preoperative Proteinuria Is Associated with Long-Term Progression to Chronic Dialysis and Mortality after Coronary Artery Bypass Grafting Surgery.
Wu V-C , Huang T-M , Wu P-C , Wang W-J , Chao C-T , et al PLoS ONE 7(1): e27687. doi:10.1371/journal.pone.0027687 2012 |
|
Importance of normohydration for the long-term survival of haemodialysis patients
Charles Chazot, Peter Wabel, Paul Chamney, Ulrich Moissl,
Sebastian Wieskotten,and Volker Wizemann
Nephrol. Dial. Transplant. first published online January 17, 2012 doi:10.1093/ndt/gfr678 |
Nathalie C. Péquériaux, Rob Fijnheer, Eugenie F. Gemen, Arjan D. Barendrecht, Friedo W. Dekker, Raymond T. Krediet, Jaap J. Beutler, Elisabeth W. Boeschoten, and Mark Roest
Nephrol. Dial. Transplant. first published online December 20, 2011 doi:10.1093/ndt/gfr735 |
Ellen K. Hoogeveen, Nynke Halbesma, Kenneth J. Rothman, Theo Stijnen, Sandra van Dijk, Friedo W. Dekker, Elisabeth W. Boeschoten, Renée de Mutsert for the Netherlands Cooperative Study on the Adequacy of Dialysis-2,
(NECOSAD) Study, and Group
CJN.05700611; published ahead of print January 5, 2012,doi:10.2215/CJN.05700611 |
|
ASN 2011 Abstract Authors' Interview:
Effect of Oral Nutritional Supplements on Mortality in Hemodialysis Patients.
Eduardo Lacson, Jr., MD, MPH, Weiling Wang, MS, Barbara Zebrowski, RD, Michael Lazarus, MD, Raymond Hakim, MD, PhD. Fresenius Medical Care, Waltham, MA.
|
Author Interview: Sirin Jiwakanon, MD.
Change in Ankle-Brachial Indices over Time and Mortality in Diabetics with Proteinuria
ASN 2011 Abstract:
Sirin Jiwakanon, MD, Sharon G. Adler, MD, FASN, Rajnish Mehrotra, MD, FASN. Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, CA; Medicine, Hatyai Hospital, Hatyai, Songkhla, Thailand.
|
Author Interview: Dr. Len Usvyat PhD
Predictive Characteristics of Successful Hemodialysis Patient Survival in the First 120 Days of Treatment
ASN 2011Abstract: [SA-PO3024]
Len A. Usvyat, Penny Faith Palmiero, Lizette Borges, Lisa A. Pacelli, Mary T. Sullivan, Paul Balter, MD, Peter Kotanko, MD, Paul M. Zabetakis, MD.
Renal Research Institute, NY, NY.
|
Usvyat LA, Carter M, Thijssen S, Kooman JP, van der Sande FM, Zabetakis P, Balter P, Levin NW, Kotanko P.
Clin J Am Soc Nephrol. 2011 Nov 17. [Epub ahead of print]
|
|
|
|
Author Interview: Dr. Miklos Zsolt Molnar, MD, PhD
Serum Erythropoietin Level and Mortality in Kidney Transplant Recipients.
Molnar MZ, Tabak AG, Alam A, Czira ME, Rudas A, Ujszaszi A, Beko G, Novak M, Kalantar-Zadeh K, Kovesdy CP, Mucsi I.
Clin J Am Soc Nephrol. 2011 Oct 6. [Epub ahead of print]
|
Rivera, R. F., Mircoli, L., Bonforte, G., Torri, V., Monteforte, M., Stella, A. and Genovesi, S.
Hemodialysis International 2011. doi: 10.1111/j.1542-4758.2011.00572.x
|
FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
Jessica Kendrick, Alfred K. Cheung , James S. Kaufman,Tom Greene,
William L. Roberts, Gerard Smits,
Michel Chonchol, and the HOST Investigators JASN Sep 7, 2011 ASN.2010121224; published ahead of print September 7, 2011, doi:10.1681/ASN.2010121224
|
Beberashvili I, Sinuani I, Azar A, Yasur H, Shapiro G, Feldman L, Averbukh Z, Weissgarten J.
Clin J Am Soc Nephrol. 2011 Aug 18
|
Berhane AM, Weil EJ, Knowler WC, Nelson RG, Hanson RL.
Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona.
Clin J Am Soc Nephrol. 2011 Aug 18
|
Chen HA, Wang JJ, Chou CT, Chien CC, Chu CC, Sheu MJ, Lin YJ, Chen PC, Chen CHFrom Chi-Mei Medical Center, Tainan; Buddhist Tzu Chi General Hospital, Taipei Branch; and Taipei Veterans General Hospital, Taipei, Taiwan.
Rheumatol. 2011 Aug 15
|
An interview with Drs. Miklos Z Molnar and Kamyar Kalantar-Zadeh from Harbor-UCLA
High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients.
Molnar MZ, Streja E, Kovesdy CP, Budoff MJ, Nissenson AR, Krishnan M, Anker SD, Norris KC, Fonarow GC, Kalantar-Zadeh K.
Harold Simmons Center for Chronic Disease Research & Epidemiology, Los Angeles Biomedical Research Institute at Harbor-University of California Los Angeles Medical Center, Torrance, CA.
Am J Clin Nutr. 2011 Aug 3
|
|
Authors' Interview:
Drs. Nazanin Noori MD Ph.D & Kamyar Kalantar-Zadeh, MD, MPH, PhD
Dietary Omega-3 Fatty Acid, Ratio of Omega-6 to Omega-3 Intake, Inflammation, and Survival in Long-term Hemodialysis Patients.
Noori N, Dukkipati R, Kovesdy CP, Sim JJ, Feroze U, Murali SB, Bross R, Benner D, Kopple JD, Kalantar-Zadeh K.
Harold Simmons Center for Chronic Disease Research and Epidemiology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA; Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA.
Am J Kidney Dis. 2011 Jun 7.
|
Author Interview: Dr. Martin Wagner, MD MS
Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease.
Wagner M, Alam A, Zimmermann J, Rauh K, Koljaja-Batzner A, Raff U, Wanner C, Schramm L.
Clin J Am Soc Nephrol. 2011 Jul;6(7):1573-9.
University Hospital Würzburg, Department of Medicine I, Division of Nephrology, Zentrum Innere Medizin, Oberdürrbacher Strasse 6, 7080 Würzburg, Germany
|
Author Interview: Dr. Qionghong Xie
The Ratio of CRP to Prealbumin Levels Predict Mortality in Patients with Hospital-acquired Acute Kidney Injury
Xie Q, Zhou Y, Xu Z, Yang Y, Kuang D, You H, Ma S, Hao C, Gu Y, Lin S, Ding F
BMC Nephrol 2011 Jun 29; 12(1):30. |
|
|
|
Author Interview: Dr. Biagio Di Iorio
Variability of pulse wave velocity and mortality in chronic hemodialysis patients.
Torraca S, Sirico ML, Guastaferro P, Morrone LF, Nigro F, Blasio AD, Romano P, Russo D, Bellasi A, Di Iorio B Hemodial Int. 2011 Apr 25. doi: 10.1111/j.1542-4758.2011.00545.x.
SOC di Nefrologia, Solofra, Avellino, Italy SOC di Nefrologia, Sant'Angelo dè Lombardi, Avellino, Italy SOC di Nefrologia, Benevento, Italy SOC di Nefrologia, Azienda Universitaria "FEDERICO II," Napoli, Italy SOC di Nefrologia, Malpighi Hospital, Bologna, Italy |
|
Author Interview: Barry I. Freedman, M.D.
Glycated Albumin and Risk of Death and Hospitalizations in Diabetic Dialysis Patients.
Freedman BI, Andries L, Shihabi ZK, Rocco MV, Byers JR, Cardona CY, Pickard MA, Henderson DL, Sadler MV, Courchene LM, Jordan JR, Balderston SS, Graham AD, Mauck VL, Russell GB, Bleyer AJ.
Clin J Am Soc Nephrol. 2011 May 19. |
Author Interview: Dr Clec'h Christophe, MD, PhD
Multiple-center evaluation of mortality associated with acute kidney injury in critically ill patients: a competing risks analysis.
Crit Care. 2011 May 17;15(3):R128.
Clec'h C, Gonzalez F, Lautrette A, Nguile-Makao M, Garrouste-Orgeas M, Jamali S, Goldgran-Toledano D, Descorps-Declere A, Chemouni F, Hamidfar-Roy R, Azoulay E, Timsit JF |
T. Christopher Bond, Allen R. Nissenson, Mahesh Krishnan, Steven M. Wilson,
Tracy Mayne
CJASN May 2011 CJN.10391110
|
|
|
Author Interview: Dr. Dorien M. Zelle,
Low Physical Activity and Risk of Cardiovascular and All-Cause Mortality in Renal Transplant Recipients
Dorien M. Zelle, Eva Corpeleijn, Ronald P. Stolk, Mathieu H.G. de Greef, Rijk O.B. Gans, Jaap J. Homan van der Heide, Gerjan Navis, and Stephan J.L. Bakker
Dr. Dorien M. Zelle, Department of Nephrology, University Medical Center Groningen, Sector A, PO Box 30001, 9700 RB, Groningen, The Netherlands
CJASN April 2011 6):(4)898-905, doi:10.2215/CJN.03340410
|
Inoshita H, Ohsawa I, Kusaba G, Ishii M, Onda K, Horikoshi S, Ohi H, Tomino Y.
BMC Nephrol. 2010 Dec 6;11:34.
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
|
|
Lai CF, Liao CH, Pai MF, Chu FY, Hsu SP, Chen HY, Yang JY, Chiu YL, Peng YS, Chang SC, Hung KY, Tsai TJ, Wu KD.
Department of Internal Medicine, Far Eastern Memorial Hospital, No. 21, Nan-Ya South Road, Ban Ciao City, Taipei, 220, Taiwan
|
Abdel-Rahman EM, Yan G, Turgut F, Balogun RA.
Division of Nephrology, Department of Medicine, University of Virginia Health System, Charlottesville, Va.
|
Am J Med. 2011 Jan;124(1):77-84.
Waikar SS, Curhan GC, Brunelli SM.
Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.
|
|
|
Association between estimated glomerular filtration rate at initiation of dialysis and mortality
Published online ahead of print December 6, 2010
CMAJ 10.1503/cmaj.100349
William F. Clark, et al
Background: : Recent studies have reported a trend toward earlier initiation of dialysis (i.e., at higher levels of glomerular filtration rate) and an association between early initiation and increased risk of death. We examined trends in initiation of hemodialysis within Canada and compared the risk of death between patients with early and late initiation of dialysis.
|
Increased Hospital Admissions on Mondays and Tuesdays in Hemodialysis Patients
Eduardo K. Lacson, Shu-Fang Lin, J. Michael Lazarus, Raymond M. Hakim. Fresenius Medical Care, North America, Waltham, MA
Introduction: Sudden deaths in hemodialysis (HD) patients occur more frequently on Mondays and Tuesdays, after the longest interdialytic period on a thrice weekly treatment schedule (3Tx/Wk). We hypothesized that hospitalization for all causes and more specifically for conditions due to fluid overload occur in a similar pattern.
|
Takenaka T, Sato T, Hoshi H, Kato N, Sueyoshi K, Tsuda M, Watanabe Y, Takane H,
Cardiol Res Pract. 2010 Nov 11;2011:242353.
Ohno Y, Suzuki H.
Department of Medicine, Saitama Medical College, 38 Moro-hongo, Moroyama, Iruma, Saitama 395-0495, Japan
|
Scand J Urol Nephrol. 2010 Nov 22.
Hallén J, Madsen L, Ladefoged S, Fagerland MW, Serebruany VL, Agewall S, Atar D.
Department of Cardiology, Oslo University Hospital, Aker and Ullevaal, Oslo, Norway.
|
Catheter Reduction Reduces Hospitalization and Mortality
Renee Jg Arnold, David Madigan, John A. Robertson, Abbe Volz. DaVita Inc., Denver, CO
Date: Friday, November 19, 2010
Introduction: Use of central venous catheters (CVC) in hemodialysis patients is associated with increased hospitalization and mortality. Published data have shown that an aggressive catheter reduction initiative (CathAway™) can decrease both catheter incidence and duration. We examined the impact of CathAway™ on hospitalization and mortality in the last 15 months of this program.
Read the Author Interview:
Catheter Reduction Reduces Hospitalization and Mortality
|
|
Arch Intern Med. 2010 Nov 8.
Rosansky SJ, Eggers P, Jackson K, Glassock R, Clark WF.
Wm. Jennings Bryan Dorn Veterans Hospital, Columbia, South Carolina (Drs Rosansky); Arnold School of Public Health, University of South Carolina, Columbia (Dr Rosansky and Mr Jackson); National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland (Dr Eggers); Geffen School of Medicine at University of California, Los Angeles (Dr Glassock); and Division of Nephrology, London Health Sciences Centre, London, Ontario, Canada (Dr Clark).
|
Published online ahead of print October 25, 2010
CMAJ 10.1503/cmaj.100347
|
Washington, DC (October 18, 2010) — Dialysis patients with little social support from
friends and family are more likely to ignore doctors’ orders, experience a poorer quality
of life, and die prematurely, according to a study appearing in an upcoming issue of the
Clinical Journal of the American Society Nephrology (CJASN). The results suggest strong
social networks are important for maintaining dialysis patients’ health.
|
Kidney Int. 2010 Oct 20.
Raphael KL, Wei G, Baird BC, Greene T, Beddhu S.
[1] VA Healthcare System, Salt Lake City, Utah, USA [2] Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
|
Hemodial Int. 2010 Oct;14(4):478-85.
doi: 10.1111/j.1542-4758.2010.00468.x.
Chang TI, Paik J, Greene T, Miskulin DC, Chertow GM.
Divisions of Nephrology General Internal Medicine, Stanford University School of Medicine, Palo Alto, California, USA Research Service, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah, USA Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA Tufts-New England Medical Center, Division of Nephrology, Boston, Massachusetts, USA.
|
Patients with Large Upper Arm Muscles Gain Improved Health and Survival
Washington, DC (October 8, 2010) — Kidney disease patients are healthier and live
longer if they’ve beefed up their muscles, according to a study appearing in an
upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that patients may benefit from pumping iron or taking medications to boost their lean body mass.
|
Nephrol Dial Transplant. 2010 Oct 4.
Chilcot J, Davenport A, Wellsted D, Firth J, Farrington K.
1Renal Unit Lister Hospital, Stevenage, UK.
|
Clin J Am Soc Nephrol. 2009 Aug;4(8):1324-30.
Coritsidis G, Sutariya D, Stern A, Gupta G, Carvounis C, Arora R, Balmir S, Acharya A.
|
Mortality Studies in Dialysis Hemodialysis and Peritoneal Dialysis Patients
Clin J Am Soc Nephrol. 2010 Sep 28.
Spiegel B, Bolus R, Desai AA, Zagar P, Parker T, Moran J, Solomon MD, Khawar O, Gitlin M, Talley J, Nissenson A.
VA Greater Los Angeles Healthcare System, Los Angeles, California |
OBJECTIVE: We examined the hypothesis that higher FM and LBM are associated with greater survival in MHD patents irrespective of sex.
Am J Clin Nutr. 2010 Sep 15. |
J Ren Nutr. 2010 Sep 10
Campbell KL, Maclaughlin HL.
Nutritional Sciences Division, King's College, London, United Kingdom; Department of Nutrition and Dietetics, King's College Hospital, London, United Kingdom.
|
Iseki K,et al.
Dialysis Unit, University Hospital of the Ryukyus, 207 Uehara, Nishihara, Okinawa 903-0215, Japan.
|
Am J Nephrol. 2010 Sep 3;32(5):403-413.
Miller JE, Kovesdy CP, Norris KC, Mehrotra R, Nissenson AR, Kopple JD, Kalantar-Zadeh K.
Harold Simmons Center for Kidney Disease Research and Epidemiology,Torrance, Calif
|
Griva K, Stygall J, Hankins M, Davenport A, Harrison M, Newman SP.
Am J Kidney Dis. 2010 Aug 25.
Department of Psychology, National University of Singapore, Singapore; Unit of Behavioural Medicine, University College London and Health Services Research Group, City University London, London, UK.
|
Am J Kidney Dis. 2010 Aug 27.
Weinhandl ED, Peng Y, Gilbertson DT, Bradbury BD, Collins AJ.
Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN.
|
Eur J Cardiothorac Surg. 2010 Aug 23.
Li SY, et al
Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital and School of Medicine, National Yang-Ming University, Taipei, Taiwan
|
März W, Meinitzer A, et al
Circulation. 2010 Aug 23.
|
|
Nephron Clin Pract. 2010 Aug 14;117(2):c167-c178.
Kawaguchi T, Tong L, Robinson BM, Sen A, Fukuhara S, Kurokawa K, Canaud B, Lameire N, Port FK, Pisoni RL.
Department of Epidemiology and Healthcare Research, Kyoto University, Graduate School of Medicine and Public Health, Kyoto, Japan.
|
Curr Opin Nephrol Hypertens. 2010 Aug 4.
Singh AK.
Renal Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
|
Clin J Am Soc Nephrol. 2010 Aug 5.
Eddington H, et al
Salford Royal NHS Foundation Trust, Salford, United Kingdom; and.
|
J Am Soc Nephrol. 2010 Jul 29.
Cavanaugh KL, et al
|
Clin J Am Soc Nephrol. 2010 Jul 22.
Gungor O, et al
Ege University School of Medicine, Izmir, Turkey
|
Tahira P. Alves, et al for the AASK Collaborative Research Group
Journal of the American Society of Nephrology
Volume 21, Issue 7, July 2010
doi: 10.1681/ASN.2009060654
|
BMC Med Inform Decis Mak. 2007 Nov 28;7:38.
Pollak VE, Lorch JA.
MIQS Inc,, 2100 Central Avenue, Suite 201, Boulder, Colorado 80301, USA
|
Nephron Clin Pract. 2010 Jul 16;116(4):c300-c306.
Szeto CC, et al
Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, SAR, China.
|
|
Clin Nephrol. 2010 Aug;74(2):91-6.
Beddhu S, et al
|
|
|
|
J Nephrol. 2010 May 28.
Kao TW et al.
|
|
Author Interviews: hemodialysis
- Dialysis - ESRD - CKD |
| Characterizing Missed Dialysis Sessions in the ESRD Patient population |
| Hemoglobin Recovery following Hospitalization in ESRD patients |
| Association of Serum Sodium Levels with Mortality in Non-Dialysis Dependent Chronic Kidney Disease |
| Talking Control Support in Hemodialysis Results in Higher Patient Satisfaction Survey Response |
| Use of Fondparinux in Severe Renal Impairment & Hemodialysis |
| Contribution of CA, phosphorus & 25-VitD to the excessive severity of sPTH in African-Americans with CKD |
| Comparison of Risk Prediction Using the CKD-EPI Equation & the MDRD Study Equation for eGFR |
| Iron-Based Phosphate Binder PA21: Effective and Well Tolerated in CKD Hemodialysis Patients |
| Hemoglobin Recovery following Hospitalization in ESRD patients |
| Disease Management Program ESRD Patients Have Lower Overall Medical Costs |
Crit-Line Monitor Use in Incident Hemodialysis Patients Improves Dry Weight and Adequacy,
While Reducing Epoetin Alfa Dose: A Propensity Score Matched Study |
| Perceptions & Roles of Nephrology Social Worker Within the Suicide Continuum of Care |
| Reduced Use of ESAs and IV Iron with Ferric Citrate: A Medicare Bundle Cost-Offset Model |
| Video Education Increases Patient Knowledge About Phosphorus Control |
| Effect of a plasma sodium biofeedback system applied to HFR on the intradialytic cardiovascular stability |
| Hemodialysis Access and Age-related Postoperative Outcomes: Which Fistula First? |
| Coronary Artery Calcification & Pre-Hemodialysis Bicarbonate Levels in Hemodialysis |
| Protein/omega-3 supplementation during regular dialysis sessions & inflammatory indices in hemodialysis |
| VDRA and improved survival in dialysis patients with serum intact PTH ≤150 pg/mL |
| Relation of social support to mental health and locus of control in Chronic Kidney Disease |
| Depression and anxiety in patients with chronic renal failure |
| Self -esteem in Greek dialysis patients: The contribution of health locus of control |
| Medication adherence in Greek hemodialysis patients: Contribution of depression and health cognition. |
| Association of insomnia with kidney disease quality of life reported by patients on maintenance dialysis |
| Comorbidities/ inactivity & long-term outcomes of CABG in small number of men on chronic hemodialysis |
| Complete Recovery From Acute Kidney Injury With Incident CKD Stage 3 and All-Cause Mortalit |
| Outcomes of patients with ESRD under chronic hemodialysis requiring CRRT & in AKI requiring CRRT |
| Radiologically Placed Tunneled Hemodialysis Catheters: Pediatric Institutional Experience of 120 Patients |
| Preload dependence of gated cardiac SPECT-derived ventricular volumes in hemodialysis |
| Effect of Hemoglobin Target on Progression of Kidney Disease |
| eGFR at Reinitiation of Dialysis & Mortality in Failed Kidney Tranplant Recipients |
| Biomarkers Determining Cardiovascular Risk in Kidney Disease |
| Rural and Micropolitan Residence & Mortality in Dialysis |
| Urinalysis is more specific & urinary NGAL is more sensitive for early AKI detection |
| Vascular Klotho Deficiency Potentiates Development of Arterial Calcification & Mediates FGF23 Resistance |
| Efficacy of preventing hemodialysis catheter infections with citrate lock: Hemodialysis Int'l |
| Learn about dialysis options from a Home Dialysis Therapy Nurse |
| Optimal fluid control can normalize CV risk markers and limit LV hypertrophy in thrice weekly dialysis |
| LDL, atherosclerosis and mortality in hemodialysis |
| Pulmonary hypertension in chronic kidney disease on dialysis/ without dialysis |
| Predictors of steal syndrome in hemodialysis Hemodialysis Int'l |
| Sodium intake and blood pressure in renal transplant recipients Nephrology Dialysis Transplant |
| HIV-associated nephropathy patients with & without apolipoprotein L1 gene variants Kidney International |
| Depression and nonadherence predict mortality in hemodialysis treated ESRD patients Hemodialysis Int'l |
| Serum Metabolite Concentrations and Decreased GFR in the General Population AJKD |
| High Volume Peritoneal Dialysis in Acute Kidney Injury CJASN |
| Trial of Catheters of Different Lengths to Achieve Right Atrium vs SVC Placement for CRRT AJKidneyDs |
Pre-kidney transplant ESA agence responsiveness with post-transplant outcomes
Nephrology Dialysis Transplant |
| Prognostic Value of 48-Hour Ambulatory BP & CV Mortality in Hemodialysis Kidney Blood Press Res |
| Darbepoetin-α Cardiovascular Geometry and CKD -Cardiorenal Med |
| Influenza Vaccine Effectiveness in Patients on Hemodialysis Arch Intern Med |
| Bioelectrical Impedance Analysis & Skinfold Thickness Sum in Body Fat Mass in Dialysis J.Renal Nutrition |
| Pre-Diabetes after Renal Transplantation Nephrology Dialysis Transplant |
| Essential trace element status and clinical outcomes in long-term dialysis |
| End-of-Life Decision-Making Confidence in Surrogates of AA Dialysis Patients Is Overly Optimistic |
| Comparison of Cardiac PET Perfusion Defects During Stress Induced by Hemodialysis vs Adenosine AJKD |
| Mental Health over Time & Cardiac Outcomes in HEMO Study CJASN |
| Cholesterol Synthesis, Cholesterol Absorption, & Mortality in Hemodialysis CJASN |
| Statins, Risk & Outcome in Acute Kidney Injury in Community-Acquired Pneumonia CJASN |
| Dialysis-Dependent Changes in Ventricular Repolarization |
| High Burden of Kidney Disease in Youth-Onset Type 2 Diabetes Diabetes Care |
| Late Start Dialysis & Outcomes in Japanese Dialysis: Therapeutic Apheresis & Dialysis |
| Pica in Pediatric Dialysis - J.Renal Nutrition |
| Elemental Concentrations in Scalp Hair in Hemodialysis Patients Therapeutic Apheresis & Dialysis |
Health-related QOL was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial
Kidney Int'l |
| Sevelamer on HbA1c, Inflammation, & Advanced Glycation End Products in Diabetic Kidney Disease CJASN |
| Increasing organ donation via anticipated regret proposed protocol |
| Statins on Chronic Inflammation and Nutrition status in Renal Dialysis |
| Emergency Department Use of Urinary Biomarkers of Nephron Damage |
| Preemptive renal transplant survival, access to care, & renal function at listing Nephrology Dialysis Transplant |
| Effect of Diuretic Use on 30-Day Postdialysis Mortality in Critically Ill Patients Receiving Acute Dialysis Dr. Ko |
| FGF23 predicts incident cardiovascular event before but not after the start of dialysis Dr. Isaka |
| Mortality Prediction by Surrogates of Body Composition: An Examination of the Obesity Paradox in Hemodialysis Using Composite Ranking Score Analysis: Drs. Miklos Z Molnar & Kamyar Kalantar-Zadeh |
| Plasma Sodium & Blood Pressure in Hemodialysis J.Human Hypertension |
| Increased Risk of Death in Young African American Dialysis Patient: Dr. Norman |
| Nutritional Management of Stage 5 CKD J. Renal Nutrition |
A proposed management algorithm for fistulae between hemodialysis access circuits and adjacent veins
Vasc Access |
| Percutaneous approach in maintenance & salvage of dysfunctional autologous vascular access for dialysis |
| The Kidney Disease Quality of Life Cognitive Function Subscale and Cognitive Performance in Maintenance Hemodialysis Patients Amer. J Kidney Diseases |
| Absolute Interdialytic Weight Gain is more important than Percent Weight Gain for Intradialytic Hypotension in heavy hemodialysis patients: Dr. Chen Nephrology |
| Postdialysis BP rise predicts outcomes in hemodialysis: Dr Yang BMC Nephrology |
| APOL1 allelic variants are associated with lower age of dialysis initiation Nephrology Dialysis Transplant |
| Effects of Six versus Three Times per Week Hemodialysis on Physical Performance, Health, and Functioning: Frequent Hemodialysis Network (FHN) Randomized Trials Dr. Hall CJASN |
| Variability of blood pressure in dialysis patients: a new marker of cardiovascular risk Dr. Di Iorio |
| Assessment of Body Composition Using Dry Mass Index and Ratio of Total Body Water to Estimated Volume Based on Bioelectrical Impedance Analysis in CKD J. Renal Nutrition |
| Potential Role of Active Vitamin D Treatment in Telomere Length in Hemodialysis: Dr Valdivielso |
| CKD, severe arterial & arteriolar sclerosis & kidney neoplasia MELAS syndrome Dr. Piccoli BMC Nephrology |
| Pedometer-Assessed Physical Activity in Children and Young Adults with CKD |
| Effect of Frequent or Extended Hemodialysis on Cardiovascular Parameters Amer J. Kidney Ds |
| Exposure to bisphenol A is associated with low-grade albuminuria in Chinese adults Dr. Guang Kidney Int'l |
| Increased dietary sodium and greater mortality in hemodialysis Kidney Int'l |
| Sonography Characteristics of the Intra-Dialysis-Graft Thrombus Dr. Cheng |
Featured Hemodialysis Interviews |
Home Dialysis Summit Recommends Policy Changes to Increase Home Dialysis Usage
WASHINGTON, April 25, 2012 /PRNewswire -- On the heels of the first National Summit on Home Dialysis Policy, Summit organizers released a report reflecting the views of the delegates -- leaders in the kidney disease patient, clinician, facility and industry communities -- on federal policy steps to improve utilization of home dialysis for patients who can benefit from this often advantageous form of treatment. Many of the organizers also announced they have formed a new alliance, called the Alliance for Home Dialysis, to advance the recommendations identified at the Summit.
The Summit's "Report of the Delegates" highlights key findings from a March 29th meeting in Washington, DC where experts probed why, despite widely accepted and well-documented benefits of home dialysis -- improved outcomes, enhanced patient satisfaction, improved quality of life, and lower costs-- fewer than ten percent of the more than 390,000 current U.S. dialysis patients receive treatment at home. Current rates of home dialysis utilization reflect a steep decline from the 1970s, when almost 40% of U.S. dialysis patients were treated in-home.
Specifically, delegates found that policymakers should work with stakeholders in the dialysis community to confront three areas:
Accessibility: Patients and clinicians face array of hurdles in education, training, and infrastructure that hinder equalized access to home dialysis.
Accountability: Utilization of home dialysis can be improved through measures within government programs that are designed to recognize and support excellence in the delivery of home dialysis services.
Aligning Incentives: Reimbursement policies, regulation of new technologies and other policy incentives can be realigned to better support federal policy goals of expanding access to home dialysis.
The Report includes 15 recommendations to serve these goals, including that federal policymakers should:
Maintain parity for home and in-center dialysis in Medicare reimbursement;
Support home dialysis mentoring programs, particularly those that use existing patients as mentors; and
Align federal and state regulatory requirements for home therapies, such as revising the Centers for Medicare and Medicaid Services Conditions for Coverage requirements, to reflect differences in home and in-center dialysis.
Summit supporters will begin work through the new Alliance to dialogue with federal policymakers and advance policy improvements in the three consensus areas that emerged at the Summit.
SOURCE National Summit on Home Dialysis Policy
|
| |
National Kidney Foundation's Top 10 Things Every Dialysis Patient Should Know.
- You have treatment choices. Options exist for how, where and when you dialyze. Dialysis can be done in a hospital, in a dialysis unit that is not part of a hospital, or at home. You and your doctor will decide which place is best, based on your medical condition and your wishes. There are different types of dialysis - peritoneal and hemodialysis. Work with your health care team to determine a treatment plan that makes you feel comfortable. Recent studies show that the majority of patients beginning in-center hemodialysis (HD) know very little, if anything, about the option to dialyze at home. Once informed, 40% or more of patients are interested in this treatment option, and yet less than 10% actually begin home dialysis. If you're dissatisfied with the type of dialysis treatment that you're receiving, ask your healthcare team if another type of dialysis treatment would be better.
- You can compare in-center dialysis facilities online. Information on over 5,600 US-based dialysis centers is available online through the Medicare website. To help you make choices about your care, you can compare different facilities side-by-side and evaluate each facility based upon clinic characteristics and quality measures. You can search for dialysis facilities by name or geographic proximity. After completing an initial facility comparison to determine which facilities best meet your needs - such as the number of hemodialysis stations at a particular location and whether there are evening shifts available - visit the facilities that you're most interested in. Talk to the staff and other patients, as well as your doctor to ensure that this dialysis facility is a good fit for you.
- There are ways to prepare ahead for an emergency. Ask your dialysis facility about their emergency plan in case of a snow storm, fire, power outage or other natural disaster. As back up, make sure you have the names, locations and phone numbers of other dialysis units and hospitals in your area. Since regular community transportation services may not be working in an emergency, be prepared to make other arrangements for getting to dialysis. You may need to contact the police and Emergency Medical Services (EMS) for assistance. If you dialyze at home, make sure you have at least two weeks' worth of unexpired supplies on hand. If you have to miss a dialysis treatment, begin your emergency meal plan.
- There is an easy way to transfer patient records between clinics. There is an easy, secure way for your health care team to transfer your treatment records online. In 2009, the Centers for Medicare and Medicaid Services (CMS) created a centralized web-based data collection system called CROWNWeb to help reduce and eliminate patient treatment interruptions. This central system helps to streamline patient care regardless of the reason for changing dialysis centers. For example, if you've been admitted to the hospital, or if you needed to relocate during an emergency evacuation, your doctors and health care team can access up-to-date information about your dialysis so that you continue to receive appropriate care no matter where you are.
- You can travel while on dialysis.
Dialysis centers are located in every part of the United States and in many foreign countries. The treatment is standardized, but you need to plan ahead by making an appointment for dialysis at another center before you go. The staff at your center may help you make these appointments.
- You can be your own best advocate. Know what key questions to ask your doctor or other healthcare professionals. Take notes so that you can refer back to them later. Partner with your doctor and decide on a treatment plan together. Advocate for yourself and share how you're feeling.
- You have many rights. You as a patient have a great deal of control over your treatments. Patients have a bill of rights which includes receiving quality care, counseling about your medical information, and an expectation of privacy.
You also have responsibilities. Once you decide on a course of treatment, it's important to follow the recommendations of your health care team. If you decide to receive in-center dialysis, arrive at dialysis on time so that you can receive the full treatment without delays.
- You can receive insurance coverage. If you have end stage renal failure, you are likely eligible for Medicare insurance coverage. Speak with your health care team and social worker for help filling out insurance paperwork.
- You may need to follow a special diet. When your kidneys are not working properly, you may not be able to eat everything you like, and you may need to limit how much you drink. Your diet may vary according to the type of dialysis you receive. It is important to speak with a renal dietitian so that you are able to understand what you can and cannot eat based on your full health history.
- Dialysis patients can work. Many dialysis patients can go back to work or school after they have gotten used to dialysis. After establishing a dialysis routine, many patients have more energy and find that they are able to time to work around this new schedule. Some patients even find creative ways to work remotely from dialysis with the use of a laptop or cell phone, depending on their field of expertise.
More from National Kidney Foundation Press Releases
|
|
New Book to Help Educate Patients with Chronic Kidney Disease who may be facing Dialysis or Hemodialysis: |
Help, I Need Dialysis!
How to have a good future with kidney disease
By Dori Schatell, MS and Dr. John Agar
An internationally known nephrologist and life-long kidney patient educator explain how dialysis works, each of the ways to do it, and how your treatment choice may affect your diet, energy level, work, travel, sexuality and fertility, sleep, and survival. Comprehensive and fully referenced, this book is a must-read if you face the life-changing choices that come with kidney failure. |
|
hemodialysis Keywords | hemodialysis Tags | hemodialysis Keyword Cloud
|
|
|
